Clinical Diagnostic Accuracy in Parkinson's Disease

The clinical diagnosis of Parkinson’s disease relies chiefly on the presence of characteristic motor signs such as bradykinesia, resting tremor and rigidity, augmented by supportive features including a robust response to dopaminergic therapy and the emergence of non-motor symptoms. Despite successive refinements to diagnostic criteria over the past decades, clinicopathological studies have repeatedly shown that approximately one in five patients diagnosed in life with idiopathic Parkinson’s disease harbour an alternative pathology at autopsy, most commonly atypical parkinsonian syndromes or dementia with Lewy bodies. This discrepancy underlines the reliance on clinical expertise and the absence of definitive in vivo biomarkers. Sensitivity and specificity of clinical assessment improve with length of follow-up, application of standardised criteria and multidisciplinary evaluation, yet even specialist assessment may falter in early or atypical presentations. Emerging approaches aim to integrate quantitative motor analyses, non-motor symptom profiling, neuroimaging and digital biomarkers to refine accuracy, facilitate earlier diagnosis and inform stratified therapeutic approaches. Accurate clinical classification is essential not only for individual patient care but also for the validity of research cohorts in trials of disease-modifying therapies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Clinical Diagnostic Accuracy in Parkinson's Disease publication trend

The graph below shows the total number of articles in clinical diagnostic accuracy in parkinson's disease across all publications each year (not limited to Nature Index journals).

Technical terms

Sensitivity: The proportion of true Parkinson’s disease cases correctly identified by a diagnostic test or clinical assessment.

Specificity: The proportion of individuals without Parkinson’s disease correctly recognised as disease-free by a diagnostic test or clinical assessment.

Receiver operating characteristic curve (ROC curve): A graphical plot that illustrates the diagnostic performance of a test across a range of thresholds by showing the trade-off between sensitivity and specificity.

Prodromal stage: The phase in which early non-motor or subtle motor signs appear before the full clinical syndrome of Parkinson’s disease is established.

Dysarthria: A motor speech disorder resulting from impaired control of the muscles used for speaking, often manifesting as slurred or slow speech.

References

1. Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case–Control Study. Annals of Neurology (2025).
2. Using sustained vowels to identify patients with mild Parkinson’s disease in a Chinese dataset. Frontiers in Aging Neuroscience (2024).
3. Parkinson’s disease: A scoping review of the quantitative and qualitative evidence of its diagnostic accuracy in primary care. British Journal of General Practice (2023).